Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-770-2 | CAS number: 5973-71-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral LD50 of the test material in the female Sprague-Dawley rat was >2000 mg/kg body weight (OECD 423, GLP).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- calculation (if not (Q)SAR)
- Remarks:
- Migrated phrase: estimated by calculation
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Safepharm Laboratories Ltd., Shardlow Business Park, Shardlow, Derbyshire, DE72 2GD, UK
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, Margate, Kent, UK.
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 200-208 g
- Fasting period before study: yes, overnight
- Housing: The animals were housed in groups of three is suspended solid-floor polypropylene cages furnished with woodflakes
- Diet: Certified Rat and Mouse Diet (Code 5LF2) supplied by BCN IPS Limited, London, UK), ad libitumwith the exception of an overnight fast immediately before dosing and for approximately three to four hours after dosing
- Water: ad libitum with the exception of an overnight fast immediately before dosing and for approximately three to four hours after dosing
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): ≥15
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 1.98 mL/kg
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- A group of 3 females, followed by a further group of 3 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations 0.5, 1, 2 and 4 hours after dosing and subsequently once daily for fourteen days. Body weights were recorded prior to dosing and seven and fourteen days after treatment.
- Necropsy of survivors performed: yes - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths
- Clinical signs:
- other: Signs of systemic toxicity noted in all animals during the day of dosing were hunched posture, lethargy and ataxia. Hunched posture was noted in four animals and ataxia noted in three animals one day after dosing. Animals appeared normal one or two days a
- Gross pathology:
- No abnormalities were noted at necropsy.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 of the test material in the female Sprague-Dawley rat was >2000 mg/kg body weight.
- Executive summary:
In a GLP compliant acute oral toxicity study, performed according to OECD guideline 423, a group of 3 fasted female Sprague-Dawley CD rats were treated once with the test substance (2000 mg/kg bw) by oral gavage followed by a 14 -day observation period. This was followed by a further group of 3 fasted females treated once at the same dose level. All animals survived. Signs of systemic toxicity noted during the study were hunched posture, lethargy and ataxia. Animals appeared normal one or two days after dosing. All animals showed expected gains in bodyweight over the study period, and no abnormalities were noted at necropsy. In conclusion, the acute oral LD50 of the test substance in the female Sprague-Dawley rat was estimated to be greater than 2000 mg/kg bodyweight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- GLP-compliant guideline study, klimisch 1
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In a GLP compliant acute oral toxicity study, performed according to OECD guideline 423, a group of 3 fasted female Sprague-Dawley CD rats were treated once with the test substance (2000 mg/kg bw) by oral gavage followed by a 14 -day observation period (Safepharm Laboratories Ltd.). This was followed by a further group of 3 fasted females treated once at the same dose level. All animals survived. Signs of systemic toxicity noted during the study were hunched posture, lethargy and ataxia. Animals appeared normal one or two days after dosing. All animals showed expected gains in bodyweight over the study period, and no abnormalities were noted at necropsy. In conclusion, the acute oral LD50 of the test substance in the female Sprague-Dawley rat was estimated to be greater than 2000 mg/kg bodyweight.
Justification for selection of acute toxicity – oral endpoint
Only study available, GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment.
Justification for classification or non-classification
Based on the findings of the oral acute toxicity study, classification for acute oral toxicity is not warranted according to Directive 67/548/EEC and according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.